Anticonvulsant Effect of Berberis integerrima L. Root Extracts in Mice

JAMS Journal of Acupuncture and Meridian Studies

Volumn 6, Issue 1, 2013, Pages 12-17

  Hosseinzadeh, Hossein ^a   Ramezani, Mohammad ^b   Shafaei, Hojjat ^c   Taghiabadi, Elahe ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticonvulsant; Berberis integerrima; Herbal; Maximal electroshock seizure; Pentylenetetrazole; Seizure

Indexed keywords

ALKALOID; ANTICONVULSIVE AGENT; BERBERIS INTEGERRIMA EXTRACT; DIAZEPAM; METHANOL; PLANT EXTRACT; TANNIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; BERBERIDACEAE; BERBERIS INTEGERRIMA; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; PRIORITY JOURNAL; SEIZURE;

EID: 84874459757     PISSN: 20052901     EISSN: 20938152     Source Type: Journal    
DOI: 10.1016/j.jams.2012.07.018     Document Type: Article

References (29)

1. Rezaei M., Ebadi A., Reim S., Fatahi R., Balandary A., Farrokhi N., et al. Molecular analysis of Iranian seedless barberries via SSR. Sci Hort 2011, 129:702-709.
2. Singh J., Kakkar P. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol 2009, 123:22-26.
3. Abdul Razzaq F., Alam Khan R., Feroz Z., Afroz S. Effect of Berberis aristata on lipid profile and coagulation parameters. Afr J Pharm Pharmacol 2011, 5:943-947.
4. Fatehi M., Saleh T.M., Fatehi-Hassanabad Z., Farrokhfal K., Jafarzadeh M., Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol 2005, 102:46-52.
5. Kafi M., Balandari A. Berberis Production and Processing 2002, Ferdowsi University Press, Mashhad.
6. Luo C.N., Lin X., Li W.K., Pu F., Wang L.W., Xie S.S., et al. Effect of berbamine on T-cell mediated immunity and the prevention of rejection on skin transplants in mice. J Ethnopharmacol 1998, 59:211-215.
7. Zovko Koncic Z., Kremer D., Karlovic K., Kosalec I. Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica Horvat. Food Chem Toxicol 2010, 48:2176-2180.
8. Suau R., Rico R.I., Lopez-Romero J.M., Najer F., Cuevas A. Isoquinoline alkaloids from Berberis vulgaris subsp. Australis. Phytochemistry 1998, 49:2545-2549.
9. Yesilada E., Kupeli E. Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats. J Ethnopharmacol 2002, 79:237-248.
10. Imanshahidi M., Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008, 22:999-1012.
11. Kosalec I., Gregurek B., Kremer D., Zovko M., Sankovic K., Karlovic K. Croatian barberry (Berberis croatica Horvat): a new source of berberine analysis and antimicrobial activity. World J Microbiol Biotechnol 2009, 25:145-150.
12. Kupeli E., Kosar M., Yesilada E., Husnu K., Baser C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 2002, 72:645-657.
13. Shamsa F., Ahmadiani A., Khosrokhavar R. Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Ethnopharmacol 1999, 64:161-166.
14. Ricciopo N.F. Electrophysiological effects of berberine on canine cardiac Purkinje fibers and ventricular muscle and artrial muscle of the rabbit. Br J Pharmacol 1993, 108:534-537.
15. Nassiri-Asl M., Hosseinzadeh H., Mortazavi S.R. Effects of Berberis vulgaris fruit extracts and its active component, berberine, on morphine dependence, hypnosis and locomotor activity in mice. Pharmacologyonline 2007, 1:190-202.
16. Kulkarni S.K., Dhir A. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 2007, 569:77-83.
17. Kulkarni S.K., Dhir A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 2010, 24:317-324.
18. Shanbhag S.M., Kulkarni H.J., Gaitonde B.B. Pharmacological actions of berberine on the central nervous system. Jpn J Pharmacol 1970, 20:482-487.
19. Hosseinzadeh H., Sadeghnia H.R. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine 2007, 14:256-262.
20. Luszczki J.J., Czuczwar P., Cioczek-Czuczwar A., Czuczwar S.J. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol 2006, 547:65-74.
21. Hosseinzadeh H., Madanifard M. Anticonvulsant effects of Coriandrum sativum L. seeds extracts in mice. Arch Iranian Med 2000, 3:182-184.
22. Ramezani M., Hosseinzadeh H., Samizadeh S. Antinociceptive effects of Zataria multiflora Boiss fractions in mice. J Ethnopharmacol 2004, 91:167-170.
23. Trease G., Evans W. Pharmacognosy 1983, Bailliere Tindall Press, London.
24. Loomis T. Essential of Toxicology 1968, Lea and Febiger, Philladelphia.
25. Vida J. Anticonvulsants. Principles of medicinal chemistry 1995, Williams and Wilkins, London. W. Foye, T. Lemke, D. Williams (Eds.).
26. de Almeida E.R., Rafael K.R., Couto G.B., Ishigami A.B. Anxiolytic and anticonvulsant effects on mice of flavonoids, linalool, and α-tocopherol presents in the extract of leaves of Cissus sicyoides L. (vitaceae). J Biomed Biotechnol 2009, 274740.
27. Ibrahim G., Abdulmumin S., Musa K.Y., Yaro A.H. Anticonvulsant activities of crude flavonoid fraction of the stem bark of Ficus sycomorus (Moraceae). J Pharmacol Toxicol 2008, 3:351-356.
28. Bhutada P., Mundhada Y., Bansod K., Dixit P., Umathe S., Mundhada D. Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav 2010, 18:207-210.
29. Wu J.F., Liu T.P., Wang J.X., Yang S.J. Effect of berberine on intracellular free CA2+ concentration in cultured brain cells. Acta Pharm Sin 1997, 32:15-19.